查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828114

2025年全球電子藥物傳輸系統市場報告

Electronic Drug Delivery Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，電子藥物輸送系統市場規模強勁成長，從2024年的111.5億美元增加至2025年的119.3億美元，複合年成長率為7.0%。預測期內的成長歸因於慢性病盛行率上升、人口老化、患者對非侵入性治療的偏好、醫療成本控制、臨床進展以及檢驗。

預計未來幾年電子藥物輸送系統市場規模將快速成長，到2029年將達到175.5億美元，複合年成長率為10.1%。預測期內的成長可歸因於藥物個人化程度的提高、全球醫療支出的增加、以患者為中心的醫療保健方法、標靶治療的興起、支持性法規環境以及遠端患者監護的進步。預測期內的主要趨勢包括人工智慧 (AI)、生物相容性材料和植入式設備的整合、特定治療領域的客製化、監管發展和標準化，以及製藥公司和科技公司之間的合作。

電子藥物輸送系統涵蓋旨在將藥物精準輸送至特定部位，同時避免非目標細胞和組織的裝置和配方。這些系統可確保藥物的可控給藥，並方便監測劑量。

電子藥物輸送系統的主要類別包括電子輸液幫浦、電子注射筆、電子自動注射器、電子吸入器、電子膠囊等。電子輸液幫浦是控制液體輸注到病人體內的醫療設備。這些幫浦部署在醫院和療養院等醫療環境中，幫助輸送營養物質和藥物等液體。電子藥物傳輸系統的關鍵組件包括感測器、無線通訊、天線、微型幫浦、流量調節器、藥物儲存器和微控制器，有電池供電和充電兩種版本。這些電子藥物傳輸系統可治療多種疾病，包括糖尿病、心血管疾病、呼吸系統疾病和多發性硬化症，並透過醫院藥局、零售藥局和線上藥局銷售。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供電子藥物輸送系統（EDM）市場統計數據，例如全球電子藥物輸送系統（EDM）行業規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的電子藥物輸送系統（EDM）市場細分、市場趨勢和機會，以及您在電子藥物輸送系統（EDM）行業取得成功所需的數據。本電子藥物輸送系統市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供全面的觀點。

未來五年預測成長率為10.1%，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自愛爾蘭和新加坡等主要地區的智慧注射裝置和劑量追蹤微晶片徵收關稅直接影響美國，從而導致精準用藥管理水平下降，並推高連網藥物輸送設備的成本。

預計電子藥物輸送系統市場的成長將受到慢性病盛行率上升的推動。慢性病病程通常超過一年，需要持續治療，而電子藥物傳遞系統可以幫助調整和監測藥物劑量，從而為這類疾病提供治療方案。例如，美國國家醫學圖書館於2023年1月報告稱，預計到2050年，美國50歲及以上患有至少一種慢性病的人數將達到1.4266億。慢性病盛行率的上升趨勢預計將刺激對電子藥物傳遞系統的需求。

預計電子藥物輸送系統市場的成長也將受到醫療設施投資增加的推動。醫療設施投資是指用於購買、開發、升級和維護醫療服務所需的基礎設施、設備、技術和其他資源的資金投入。電子藥物輸送系統的投資可以提供寶貴的藥物管理數據，並實現即時監控和分析。這使得醫療服務提供者能夠根據患者的反應做出明智的決策、識別趨勢並最佳化治療方案。例如，根據《莫斯科時報》報道，俄羅斯聯邦初級醫療保健現代化計劃在2023年撥款888億盧布（9.1億美元），並在2023年至2025年期間撥款5,500億盧布（57億美元）。因此，醫療設施投資的增加是電子藥物輸送系統市場成長的主要驅動力。

電子藥物傳輸系統市場的一個突出趨勢是技術先進、微創的藥物傳輸系統的發展。為了保持競爭力，電子藥物傳輸市場的主要企業正在推出創新且技術先進的藥物輸送系統。例如，2022年3月，德國特種化學品製造商贏創工業股份公司推出了EUDRATEC SoluFlow，這是一項旨在提高口服藥物中活性藥物成分溶解度的新型微粒技術。該技術是該公司口服藥物傳輸產品組合的一部分，旨在治療癌症、心血管疾病、感染疾病和糖尿病等疾病。

領先的公司正在與電子藥物輸送系統市場的新興企業和中型公司建立策略合作夥伴關係，以擴展其產品和服務範圍。策略夥伴關係關係是指兩個或多個組織之間的協作，以實現特定的業務目標。例如，2022年10月，專門為製藥、生物技術和非專利產業開發和製造藥物輸送設備解決方案的法國公司Nemera宣布與Zollner Elektronik AG建立合作夥伴關係。透過此次策略合作，Nemera和Zollner將結合各自在藥物傳輸設備和製藥行業的專業知識以及在醫療行業電子開發和製造方面的知識，從而增強兩家公司的能力。 Zollner Elektronik AG是一家總部位於德國的電子藥物傳輸系統服務提供者。

2022年3月，總部位於瑞士的製藥公司山德士完成了對Coalesce Product Development Limited的收購，具體金額未披露。此次收購將使山德士獲得Coalesce的研發能力，增強其現有的呼吸系統疾病治療和高品質複合療法產品組合。 Coalesce Product Development Limited是一家總部位於英國的醫療藥物輸送設備開發商。

電子藥物傳輸系統市場的主要企業包括 Gerresheimer AG、Medtronic plc、Novo Nordisk A/S、Insulet Corporation、Bayer AG、Tandem Diabetes Care、United Therapeutics Corporation、F. Hoffmann-La Roche AG、Elcamat Medical Services、Sanofi SA、Cane SpA、Findd、Johnson 和Ltd.、H& T Presspart Manufacturing Ltd.、HCmed Innovations Co.Ltd.、Amiko Digital Health Limited、CeQur Corporation、West Pharmaceutical Services Inc. 和 BIOCORP。

2024年，北美是電子藥物傳輸系統市場最大的地區。預計亞太地區將成為預測期內全球電子藥物傳輸系統市場成長最快的地區。電子藥物輸送系統市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

電子藥物輸送系統市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

電子藥物傳輸系統市場涵蓋滴鼻劑、眼藥水和避孕器的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球電子藥物傳輸系統：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球電子藥物傳輸系統市場：成長率分析
  • 全球電子藥物傳輸系統市場表現：規模與成長，2019-2024
  • 全球電子藥物傳輸系統市場預測：規模與成長，2024-2029年，2034年
  • 全球電子藥物傳輸系統：總目標市場（TAM）

第6章 市場細分

  • 全球電子藥物輸送系統市場類型、效能及預測（2019-2024、2024-2029、2034）
  • 電子輸液幫浦
  • 電子注射筆
  • 電子自動注射器
  • 電子吸入器
  • 電子膠囊
  • 其他
  • 全球電子藥物傳輸系統市場（按組件、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 感應器
  • 通訊和天線
  • 微型幫浦和流量調節器
  • 藥物儲存器
  • 微控制器
  • 其他
  • 全球電子藥物輸送系統市場（按系統類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 電池供電系統
  • 可充電系統
  • 全球電子藥物輸送系統市場（按分銷管道）：實際結果與預測（2019-2024 年、2024-2029 年、2034 年）
  • 醫院藥房
  • 零售藥局
  • 網路藥局
  • 其他
  • 全球電子藥物輸送系統市場的應用、性能和預測（2019-2024 年、2024-2029 年、2034 年）
  • 糖尿病
  • 心血管疾病
  • 呼吸系統疾病
  • 多發性硬化症
  • 其他
  • 全球電子藥物輸送系統市場：電子輸液幫浦細分、類型、性能及預測（2019-2024、2024-2029、2034）
  • 容積式輸液泵
  • 注射輸液幫浦
  • 攜帶式輸液泵
  • 全球電子藥物輸送系統市場：電子注射筆細分、類型、效能及預測（2019-2024、2024-2029、2034）
  • 胰島素筆
  • 生長激素筆
  • 其他
  • 全球電子藥物輸送系統市場：電子自動注射器細分、類型、性能及預測（2019-2024、2024-2029、2034）
  • 預填充自動注射器
  • 彈簧式自動注射器
  • 全球電子藥物輸送系統市場：電子吸入器細分市場、類型、性能及預測（2019-2024 年、2024-2029 年、2034 年）
  • 定量噴霧吸入器（MDI）
  • 乾粉吸入器（DPI）
  • 緩霧吸入器
  • 全球電子藥物輸送系統市場：電子膠囊細分市場、類型、性能及預測（2019-2024、2024-2029、2034）
  • 智慧膠囊
  • 帶感測器的數位膠囊
  • 全球電子藥物輸送系統市場：其他細分市場、按類型、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 經皮給藥系統
  • 植入式藥物傳輸系統
  • 穿戴式藥物輸送系統

第7章 區域和國家分析

  • 全球電子藥物輸送系統市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球電子藥物輸送系統市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 電子藥物輸送系統市場：競爭格局
  • 電子藥物輸送系統市場：公司簡介
    • Gerresheimer AG
    • Medtronic plc
    • Novo Nordisk A/S
    • Insulet Corporation
    • Bayer AG

第31章：其他領先和創新企業

  • Tandem Diabetes Care
  • United Therapeutics Corporation
  • F. Hoffmann-La Roche AG
  • Elcam Medical
  • Sanofi SA
  • Cane SpA
  • FindAir
  • Johnson & Johnson Services Inc.
  • Antares Pharma Inc
  • Abbott Laboratories
  • Adherium Ltd.
  • H& T Presspart Manufacturing Ltd.
  • HCmed Innovations Co. Ltd.
  • Amiko Digital Health Limited
  • CeQur Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年電子藥物輸送系統市場：提供新機會的國家
  • 2029年電子藥物傳輸系統市場：細分領域帶來新機會
  • 2029年電子藥物傳輸系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24104u

Electronic drug delivery systems encompass devices or formulations designed to facilitate the targeted delivery of a medical substance to a specific region while avoiding non-target cells and tissues. These systems ensure the controlled administration of drugs, allowing for easy monitoring of doses.

The primary categories of electronic drug delivery systems include electronic infusion pumps, electronic injection pens, electronic auto-injectors, electronic inhalers, electronic capsules, and other variants. Electronic infusion pumps are medical devices that regulate the controlled delivery of fluids into a patient's body. Deployed in healthcare settings such as hospitals and nursing homes, these pumps are instrumental in delivering fluids such as nutrients and medications. Essential components of electronic drug delivery systems comprise sensors, wireless communicators, antennas, micro-pumps, flow regulators, drug reservoirs, microcontrollers, and other elements, available in both battery-powered and rechargeable systems. These electronic drug delivery systems are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, catering to the treatment of various conditions such as diabetes, cardiovascular disease, respiratory disorders, multiple sclerosis, and other ailments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The electronic drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides electronic drug delivery systems market statistics, including electronic drug delivery systems industry global market size, regional shares, competitors with an electronic drug delivery systems market share, detailed electronic drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the electronic drug delivery systems industry. This electronic drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electronic drug delivery systems market size has grown strongly in recent years. It will grow from $11.15 billion in 2024 to $11.93 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to rising chronic diseases incidence, aging population, patient preference for non-invasive delivery, healthcare cost containment, clinical advancements, and validation.

The electronic drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $17.55 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing drug personalization, rising global healthcare expenditure, patient-centric healthcare approach, emergence of targeted therapies, supportive regulatory environment, and advancements in remote patient monitoring. Major trends in the forecast period include the incorporation of artificial intelligence (AI), biocompatible materials and implantable devices, customization for specific therapeutic areas, regulatory advancements and standardization, and collaborations between pharma and tech companies.

The forecast of 10.1% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on smart injection mechanisms and dose-tracking microchips, sourced from key regions such as Ireland and Singapore, which could lead to reduced precision medication administration and higher costs for connected drug delivery devices.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth of the electronic drug delivery systems market is expected to be driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting for more than a year and necessitating ongoing medical treatment, can benefit from electronic drug delivery systems that aid in regulating and monitoring drug doses. For example, in January 2023, the National Library of Medicine reported that the number of individuals in the US aged 50 and older with at least one chronic condition is projected to reach 142.66 million by 2050. This upward trend in chronic diseases is poised to fuel the demand for electronic drug delivery systems.

The growth of the electronic drug delivery systems market is also anticipated to be propelled by the increasing investment in healthcare facilities. Investment in healthcare facilities involves financial commitments for acquiring, developing, upgrading, or maintaining infrastructure, equipment, technology, and other resources essential for healthcare service provision. Investments in electronic drug delivery systems contribute valuable data on medication administration, enabling real-time monitoring and analytics. This empowers healthcare providers to make informed decisions, identify trends, and optimize treatment plans based on patient responses. For instance, as reported by The Moscow Times, Russia's federal project on modernizing primary healthcare plans to allocate 88.8 billion rubles ($910 million) in 2023 and 550 billion rubles ($5.7 billion) for 2023-25. Consequently, the increasing investment in healthcare facilities is a significant driver of the electronic drug delivery systems market's growth.

A prominent trend in the electronic drug delivery system market is the development of technologically advanced and minimally invasive drug delivery systems. Leading companies in the electronic drug delivery market are introducing innovative and technologically sophisticated drug delivery systems to maintain their competitive positions. For example, in March 2022, Evonik Industries AG, a Germany-based specialty chemicals company, unveiled EUDRATEC SoluFlow, a novel microparticle technology designed to enhance the solubility of active pharmaceutical ingredients in oral drug products. This technology, part of the company's oral drug delivery portfolio, is aimed at addressing diseases such as cancer, cardiovascular diseases, infectious diseases, and diabetes.

Major companies are strategically forming partnerships and collaborations with startups and mid-sized companies in the electronic drug delivery system market to expand their product and service offerings. Strategic partnerships involve collaborative relationships between two or more organizations to achieve specific business objectives or goals. For instance, in October 2022, Nemera, a France-based company specializing in the development and manufacturing of drug delivery device solutions for the pharmaceutical, biotechnology, and generic industries, announced a partnership with Zollner Elektronik AG. This strategic alliance enhances both Nemera and Zollner's capabilities, combining expertise in drug delivery devices and the pharmaceutical industry with electronics development and manufacturing knowledge in the medical industry. Zollner Elektronik AG is a Germany-based provider of Electronic Drug Delivery Systems services.

In March 2022, Sandoz, a Switzerland-based pharmaceutical company, completed the acquisition of Coalesce Product Development Limited for an undisclosed amount. This acquisition equips Sandoz with Coalesce's capabilities, enhancing the company's existing portfolio of respiratory medicines and high-quality, complex therapies. Coalesce Product Development Limited is a UK-based medical and drug delivery device development company.

Major companies operating in the electronic drug delivery systems market include Gerresheimer AG, Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Bayer AG, Tandem Diabetes Care, United Therapeutics Corporation, F. Hoffmann-La Roche AG, Elcam Medical, Sanofi S.A., Cane SpA, FindAir, Johnson & Johnson Services Inc., Antares Pharma Inc, Abbott Laboratories, Adherium Ltd., H&T Presspart Manufacturing Ltd., HCmed Innovations Co. Ltd., Amiko Digital Health Limited, CeQur Corporation, West Pharmaceutical Services Inc., BIOCORP

North America was the largest region in the electronic drug delivery systems market in 2024. Asia-pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the electronic drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The electronic drug delivery systems market consists of sales of nasal sprays, eyedroppers, and intrauterine devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Electronic Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on electronic drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for electronic drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electronic drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Electronic Infusion Pumps; Electronic Injection Pens; Electronic Auto-Injectors; Electronic Inhalers; Electronic Capsules; Other Types
  • 2) By Component: Sensors; Wireless Communicator And Antennas; Micro Pumps And Flow Regulators; Drug Reservoir; Microcontroller; Other Components
  • 3) By System Type: Battery-Powered Systems; Rechargeable Systems
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 5) By Application: Diabetes; Cardiovascular Disease; Respiratory Disorders; Multiple Sclerosis; Other Applications
  • Subsegments:
  • 1) By Electronic Infusion Pumps: Volumetric Infusion Pumps; Syringe Infusion Pumps; Ambulatory Infusion Pumps
  • 2) By Electronic Injection Pens: Insulin Pens; Growth Hormone Pens; Other Injectable Medication Pens
  • 3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors; Spring-Loaded Auto-Injectors
  • 4) By Electronic Inhalers: Metered Dose Inhalers (MDI); Dry Powder Inhalers (DPI); Soft Mist Inhalers
  • 5) By Electronic Capsules: Smart Capsules; Digital Capsules With Sensors
  • 6) By Other Types: Transdermal Drug Delivery Systems; Implantable Drug Delivery Systems; Wearable Drug Delivery Systems
  • Companies Mentioned: Gerresheimer AG; Medtronic plc; Novo Nordisk A/S; Insulet Corporation; Bayer AG; Tandem Diabetes Care; United Therapeutics Corporation; F. Hoffmann-La Roche AG; Elcam Medical; Sanofi S.A.; Cane SpA; FindAir; Johnson & Johnson Services Inc.; Antares Pharma Inc; Abbott Laboratories; Adherium Ltd.; H&T Presspart Manufacturing Ltd.; HCmed Innovations Co. Ltd.; Amiko Digital Health Limited; CeQur Corporation; West Pharmaceutical Services Inc.; BIOCORP
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Electronic Drug Delivery Systems Market Characteristics

3. Electronic Drug Delivery Systems Market Trends And Strategies

4. Electronic Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Electronic Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Electronic Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Electronic Drug Delivery Systems Market Growth Rate Analysis
  • 5.4. Global Electronic Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Electronic Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Electronic Drug Delivery Systems Total Addressable Market (TAM)

6. Electronic Drug Delivery Systems Market Segmentation

  • 6.1. Global Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic Infusion Pumps
  • Electronic Injection Pens
  • Electronic Auto-Injectors
  • Electronic Inhalers
  • Electronic Capsules
  • Other Types
  • 6.2. Global Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sensors
  • Wireless Communicator And Antennas
  • Micro Pumps And Flow Regulators
  • Drug Reservoir
  • Microcontroller
  • Other Components
  • 6.3. Global Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Battery-Powered Systems
  • Rechargeable Systems
  • 6.4. Global Electronic Drug Delivery Systems Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels
  • 6.5. Global Electronic Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diabetes
  • Cardiovascular Disease
  • Respiratory Disorders
  • Multiple Sclerosis
  • Other Applications
  • 6.6. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Infusion Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Ambulatory Infusion Pumps
  • 6.7. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Injection Pens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Pens
  • Growth Hormone Pens
  • Other Injectable Medication Pens
  • 6.8. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Auto-Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pre-filled Auto-Injectors
  • Spring-Loaded Auto-Injectors
  • 6.9. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metered Dose Inhalers (MDI)
  • Dry Powder Inhalers (DPI)
  • Soft Mist Inhalers
  • 6.10. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Smart Capsules
  • Digital Capsules With Sensors
  • 6.11. Global Electronic Drug Delivery Systems Market, Segmentation By Other Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transdermal Drug Delivery Systems
  • Implantable Drug Delivery Systems
  • Wearable Drug Delivery Systems

7. Electronic Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Electronic Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Electronic Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Electronic Drug Delivery Systems Market

  • 8.1. Asia-Pacific Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Electronic Drug Delivery Systems Market

  • 9.1. China Electronic Drug Delivery Systems Market Overview
  • 9.2. China Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Electronic Drug Delivery Systems Market

  • 10.1. India Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Electronic Drug Delivery Systems Market

  • 11.1. Japan Electronic Drug Delivery Systems Market Overview
  • 11.2. Japan Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Electronic Drug Delivery Systems Market

  • 12.1. Australia Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Electronic Drug Delivery Systems Market

  • 13.1. Indonesia Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Electronic Drug Delivery Systems Market

  • 14.1. South Korea Electronic Drug Delivery Systems Market Overview
  • 14.2. South Korea Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Electronic Drug Delivery Systems Market

  • 15.1. Western Europe Electronic Drug Delivery Systems Market Overview
  • 15.2. Western Europe Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Electronic Drug Delivery Systems Market

  • 16.1. UK Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Electronic Drug Delivery Systems Market

  • 17.1. Germany Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Electronic Drug Delivery Systems Market

  • 18.1. France Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Electronic Drug Delivery Systems Market

  • 19.1. Italy Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Electronic Drug Delivery Systems Market

  • 20.1. Spain Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Electronic Drug Delivery Systems Market

  • 21.1. Eastern Europe Electronic Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Electronic Drug Delivery Systems Market

  • 22.1. Russia Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Electronic Drug Delivery Systems Market

  • 23.1. North America Electronic Drug Delivery Systems Market Overview
  • 23.2. North America Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Electronic Drug Delivery Systems Market

  • 24.1. USA Electronic Drug Delivery Systems Market Overview
  • 24.2. USA Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Electronic Drug Delivery Systems Market

  • 25.1. Canada Electronic Drug Delivery Systems Market Overview
  • 25.2. Canada Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Electronic Drug Delivery Systems Market

  • 26.1. South America Electronic Drug Delivery Systems Market Overview
  • 26.2. South America Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Electronic Drug Delivery Systems Market

  • 27.1. Brazil Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Electronic Drug Delivery Systems Market

  • 28.1. Middle East Electronic Drug Delivery Systems Market Overview
  • 28.2. Middle East Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Electronic Drug Delivery Systems Market

  • 29.1. Africa Electronic Drug Delivery Systems Market Overview
  • 29.2. Africa Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Electronic Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Electronic Drug Delivery Systems Market Competitive Landscape
  • 30.2. Electronic Drug Delivery Systems Market Company Profiles
    • 30.2.1. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Electronic Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. Tandem Diabetes Care
  • 31.2. United Therapeutics Corporation
  • 31.3. F. Hoffmann-La Roche AG
  • 31.4. Elcam Medical
  • 31.5. Sanofi S.A.
  • 31.6. Cane SpA
  • 31.7. FindAir
  • 31.8. Johnson & Johnson Services Inc.
  • 31.9. Antares Pharma Inc
  • 31.10. Abbott Laboratories
  • 31.11. Adherium Ltd.
  • 31.12. H&T Presspart Manufacturing Ltd.
  • 31.13. HCmed Innovations Co. Ltd.
  • 31.14. Amiko Digital Health Limited
  • 31.15. CeQur Corporation

32. Global Electronic Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Electronic Drug Delivery Systems Market

34. Recent Developments In The Electronic Drug Delivery Systems Market

35. Electronic Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Electronic Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Electronic Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Electronic Drug Delivery Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer